한글목차

줄기세포 치료 시장 규모는 최근 급성장하고 있습니다. 2025년 92억 6,000만 달러에서 2026년에는 105억 1,000만 달러에 이르고, CAGR 13.5%의 성장이 전망되고 있습니다. 지금까지의 성장은 기존 치료법의 제한적인 효과, 만성 및 퇴행성 질환의 유병률 증가, 학술 연구 및 임상 연구에 대한 자금 지원 증가, 골수 이식의 초기 단계의 성공, 재생의료에 대한 인식 증가 등이 요인으로 작용한 것으로 보입니다.

줄기세포 치료 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 161억 2,000만 달러에 이르고, CAGR은 11.3%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 혈액학 이외의 치료 적용 범위 확대, 병용요법을 통한 임상 결과 개선, 바이오테크 기업의 투자 증가, 규제 당국의 승인 확대, 개인 맞춤형 의료에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 세포 기반 재생의료의 확대, 자가 줄기세포 시술의 도입 증가, 다계통 질환에 대한 임상시험 증가, 줄기세포 은행 인프라의 발전, 종양학 분야에서의 줄기세포 치료의 통합 확대 등을 꼽을 수 있습니다.

맞춤형 의료의 보급 확대는 향후 몇 년간 줄기세포치료제 시장의 성장을 견인할 것으로 예측됩니다. 맞춤의료(정밀의료라고도 함)는 치료 전략을 수립할 때 유전적 요인, 환경적 요인, 생활습관의 개인차를 고려하는 헬스케어 접근법입니다. 환자의 특정 유전자 프로파일과 임상 프로파일에 따라 줄기세포 치료를 맞춤화함으로써 맞춤의료는 치료 효과를 높이고 부작용을 최소화하며 환자의 안전과 건강을 중시합니다. 이러한 환자 중심의 접근 방식은 정확한 환자 선택, 보다 효율적인 임상시험, 시장 범위 확대와 함께 줄기세포 치료의 매력도를 높이고 시장을 확대할 수 있을 것으로 기대됩니다. 예를 들어, 2024년 2월 미국 비영리단체 '맞춤의료연합'이 발표한 바에 따르면, 2023년 FDA가 승인한 희귀질환 환자를 위한 신규 맞춤치료제는 16건으로 2022년 6건보다 증가하였습니다. 승인 내용에는 암 치료 7건, 기타 질환 및 증상 치료 3건이 포함되어 있습니다. 이처럼 맞춤형 의료의 발전이 줄기세포치료제 시장 확대에 크게 기여하고 있는 것입니다.

줄기세포 치료 시장에서 활동하는 주요 기업들은 확장성, 일관성, 생산 효율성 향상을 위해 엔드투엔드 마이크로플루이딕스 기반 세포 처리 플랫폼과 같은 첨단 자동화 제조 솔루션 개발에 주력하고 있습니다. 이 플랫폼은 마이크로플루이딕스 기술을 활용하여 세포치료제 제조의 모든 필수 공정을 하나의 폐쇄적이고 정밀하며 확장 가능한 단일 프레임워크 내에서 수행하는 완전 통합형 자동화 시스템입니다. 예를 들어, 2025년 3월 스위스에 본사를 둔 세포 치료 기술 기업 Limula SA는 자가 및 동종 세포 치료제의 제조를 간소화하는 시스템 'LimONE'을 발표했습니다. LimONE은 자동화된 세포 농축, 바이오프로세싱, 최종 제형화를 하나의 모듈식 유닛에 통합하여 표준화, 확장성, 비용 효율적인 세포치료제 생산을 가능하게 합니다. LimONE은 공정의 변동성을 줄이고 연속적인 폐쇄형 제조를 실현함으로써 생산의 신뢰성을 향상시켜 줄기세포 및 기타 세포 기반 치료제의 임상적, 상업적 보급을 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Stem cell therapy is a type of regenerative medicine that utilizes stem cells or substances derived from them to activate the body's inherent healing mechanisms in tissues that are damaged, diseased, or injured. It represents an advancement beyond traditional organ transplantation by aiming to replace the need for limited donor organs with cellular-based treatments.

The primary forms of stem cell therapy include allogeneic and autologous stem cell therapy. Allogeneic stem cell transplantation involves introducing stem cells from a healthy donor into a patient's body, typically following intensive chemotherapy or radiation treatment. These cells can be obtained from several sources, such as adult stem cells, induced pluripotent stem cells, and embryonic stem cells, and are applied in the treatment of conditions including musculoskeletal diseases, wounds and injuries, cancer, autoimmune disorders, and more. Such therapies are administered through hospitals and specialized clinics.

Tariffs have influenced the stem cell therapy market by increasing the cost of importing specialized laboratory equipment, cell culture media, and cryopreservation systems used across research and clinical settings. Higher input costs have particularly impacted allogeneic stem cell therapy providers, research centers, and hospitals in regions reliant on cross-border supply chains such as Asia-Pacific and parts of Europe. These trade barriers have slowed project timelines and raised treatment costs, affecting affordability and scalability. However, tariffs have also encouraged local manufacturing, domestic sourcing of biological materials, and regional partnerships, supporting long-term supply chain resilience and localized innovation.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell therapy market size has grown rapidly in recent years. It will grow from $9.26 billion in 2025 to $10.51 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to limited effectiveness of conventional treatments, increasing prevalence of chronic and degenerative diseases, growth in academic and clinical research funding, early success of bone marrow transplantation, rising awareness of regenerative medicine.

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $16.12 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to expanding therapeutic applications beyond hematology, improving clinical outcomes through combination therapies, rising investment from biotechnology firms, increasing acceptance by regulatory authorities, growing demand for personalized medicine. Major trends in the forecast period include expansion of cell-based regenerative therapies, rising adoption of autologous stem cell procedures, increasing clinical trials for multisystem disorders, advancements in stem cell banking infrastructure, growing integration of stem cell therapy in oncology.

The expanding adoption of personalized medicine is anticipated to drive the growth of the stem cell therapy market in the coming years. Personalized medicine, often referred to as precision medicine, is a healthcare approach that considers individual differences in genetics, environment, and lifestyle when designing treatment strategies. By customizing stem cell therapies according to a patient's specific genetic and clinical profile, personalized medicine improves therapeutic outcomes, minimizes side effects, and emphasizes patient safety and well-being. This patient-focused strategy, along with accurate patient selection, more efficient clinical trials, and broader market reach, is expected to increase the attractiveness of stem cell therapies and support market expansion. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. These approvals included seven cancer therapies and three treatments targeting other diseases and conditions. Therefore, the growing advancement of personalized medicine is contributing significantly to the expansion of the stem cell therapy market.

Major companies operating in the stem cell therapy market are concentrating on the development of advanced automated manufacturing solutions, such as end-to-end microfluidic-based cell processing platforms, to enhance scalability, consistency, and production efficiency. These platforms are fully integrated automated systems that leverage microfluidic technology to carry out all essential stages of cell therapy manufacturing within a single, closed, precise, and scalable framework. For instance, in March 2025, Limula SA, a Switzerland-based cell therapy technology company, introduced LimONE, a system designed to simplify the manufacturing of both autologous and allogeneic cell therapies. LimONE integrates automated cell enrichment, bioprocessing, and final formulation into one modular unit, allowing for standardized, scalable, and cost-effective cell therapy production. By reducing process variability and enabling continuous, closed-system manufacturing, LimONE improves production reliability and supports wider clinical and commercial adoption of stem cell and other cell-based therapies.

In April 2024, Century Therapeutics Inc., a US-based biotechnology company, acquired Clade Therapeutics Inc. for an undisclosed sum. This acquisition aims to enhance Century Therapeutics' development pipeline by incorporating Clade's advanced stem cell engineering technologies, accelerating the creation of next-generation allogeneic therapies, and broadening its capabilities within immuno-oncology. Clade Therapeutics Inc. is a US-based biotechnology company specializing in the development of engineered stem cell-derived therapeutic solutions.

Major companies operating in the stem cell therapy market are Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co. Ltd., Astellas Pharma Inc., Catalent Inc., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., Stemedica Cell Technologies Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co. Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Cellerix, Cellgenix, NSgene, Tigenix, Renuron Group, Smart Cells, Genenta Science, Amsterdam Molecular Therapeutics (AMT), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Oncoarendi Therapeutics, Celon Pharma, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics, Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Gamida Cell Ltd, Hisun Pharma, Novartis

North America was the largest region in the stem cell therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy
• 2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells
• 3) By Application: Musculoskeletal Disorders and Wounds & Injuries; Cancer; Autoimmune Disorders; Others
• 4) By End-Users: Hospitals And Clinics; Research Centers; Others
• Companies Mentioned: Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc.; MEDIPOST Co. Ltd.; Astellas Pharma Inc.; Catalent Inc.; Pharmicell Co. Ltd.; JCR Pharmaceuticals Co. Ltd.; Stemedica Cell Technologies Inc.; Pluristem Technologies Ltd; Becton Dickinson Private Limited; Stem Cell Technologies India Pvt. Ltd; Cordlife India Pvt. Ltd; Lifecell International Pvt. Ltd; Stemcyte India Therapeutics Private Limited; Stempeutics Research Private Limited; Anterogen Co. Ltd; Tonghua Dongbao Pharmaceutical Co; China Biologic Products Holdings Inc; Cellerix; Cellgenix; NSgene; Tigenix; Renuron Group; Smart Cells; Genenta Science; Amsterdam Molecular Therapeutics (AMT); Ark Therapeutics; Arthrogen Bv; Diamyd Medical Ab; Oxford Biomedica; Transgene; Oncoarendi Therapeutics; Celon Pharma; Osiris Therapeutics; Capricortherapeutics; Cellular Dynamics; Discgenics; Takeda Pharmaceuticals; Kolon Tissue Gene; Athersys; Cyro-Cell International; Geron Corporation; Mesoblast Ltd; Astrom Biosciences Inc; Invitrogen; Cytori Therapeutics Inc; Nuvasive Inc; Aldagen Inc; Caladrius Biosciences Inc; Biogen Sa; Gamida Cell Ltd; Hisun Pharma; Novartis
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Stem Cell Therapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Stem Cell Therapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Stem Cell Therapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Stem Cell Therapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Expansion Of Cell-Based Regenerative Therapies
  • 4.2.2 Rising Adoption Of Autologous Stem Cell Procedures
  • 4.2.3 Increasing Clinical Trials For Multisystem Disorders
  • 4.2.4 Advancements In Stem Cell Banking Infrastructure
  • 4.2.5 Growing Integration Of Stem Cell Therapy In Oncology

5. Stem Cell Therapy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Research Centers
• 5.4 Academic & Medical Institutes
• 5.5 Biopharmaceutical Companies

6. Stem Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Stem Cell Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Stem Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Stem Cell Therapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Stem Cell Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Stem Cell Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Stem Cell Therapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Stem Cell Therapy Market Segmentation

• 9.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
• 9.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
• 9.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
• 9.4. Global Stem Cell Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research Centers, Others

10. Stem Cell Therapy Market Regional And Country Analysis

• 10.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Stem Cell Therapy Market

• 11.1. Asia-Pacific Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Stem Cell Therapy Market

• 12.1. China Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Stem Cell Therapy Market

• 13.1. India Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Stem Cell Therapy Market

• 14.1. Japan Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Stem Cell Therapy Market

• 15.1. Australia Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Stem Cell Therapy Market

• 16.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Stem Cell Therapy Market

• 17.1. South Korea Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Stem Cell Therapy Market

• 18.1. Taiwan Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Stem Cell Therapy Market

• 19.1. South East Asia Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Stem Cell Therapy Market

• 20.1. Western Europe Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Stem Cell Therapy Market

• 21.1. UK Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Stem Cell Therapy Market

• 22.1. Germany Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Stem Cell Therapy Market

• 23.1. France Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Stem Cell Therapy Market

• 24.1. Italy Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Stem Cell Therapy Market

• 25.1. Spain Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Stem Cell Therapy Market

• 26.1. Eastern Europe Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Stem Cell Therapy Market

• 27.1. Russia Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Stem Cell Therapy Market

• 28.1. North America Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Stem Cell Therapy Market

• 29.1. USA Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Stem Cell Therapy Market

• 30.1. Canada Stem Cell Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Stem Cell Therapy Market

• 31.1. South America Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Stem Cell Therapy Market

• 32.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Stem Cell Therapy Market

• 33.1. Middle East Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Stem Cell Therapy Market

• 34.1. Africa Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Stem Cell Therapy Market, Segmentation By Type, Segmentation By Cell Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Stem Cell Therapy Market Regulatory and Investment Landscape

36. Stem Cell Therapy Market Competitive Landscape And Company Profiles

• 36.1. Stem Cell Therapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Stem Cell Therapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Stem Cell Therapy Market Company Profiles
  • 36.3.1. Fujifilm Holding Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. MEDIPOST Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Stem Cell Therapy Market Other Major And Innovative Companies

• Catalent Inc., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., Stemedica Cell Technologies Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co. Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Cellerix

38. Global Stem Cell Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Stem Cell Therapy Market

40. Stem Cell Therapy Market High Potential Countries, Segments and Strategies

• 40.1 Stem Cell Therapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Stem Cell Therapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Stem Cell Therapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer